Eric Jonasch

22PUBLICATIONS
151CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 15, 2026
Explainable machine learning/artificial intelligence model for estimating postoperative survival in renal cell carcinoma brain metastasis patients.

|Mar 03, 2026
Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma.

Kabir Grewal, Maria Julia Moura Nascimento Santos, Pankaj Kumar Chauhan

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Jun 23, 2025
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma.

Kathryn E Beckermann, Neil J Shah, Matthew T Campbell

|Apr 11, 2025
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC.

Andrew W Hahn, Nabil Adra, Ulka Vaishampayan

|Feb 12, 2025
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma.

Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson

Pageof 4

Frequent Collaborators

7 joint publications

Pavlos Msaouel

6 joint publications

Nizar M Tannir

5 joint publications

Jianjun Gao

4 joint publications

Toni K Choueiri